Guoda Lian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guoda Lian has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Jiajia Li
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China
1 shared publication - Jinmao Zou
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China
1 shared publication - Kaihong Huang
Department of Gastroenterology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
1 shared publication - Linjuan Zeng
Cancer Center of the Fifth Affiliated Hospital Sun Yat‐sen University Zhuhai Guangdong 519000 China
1 shared publication - Shangxiang Chen
Department of General Surgery, The 1st Affiliated Hospital, Jiangxi Medical College, Nanchang University, 330006 Nanchang, Jiangxi, China
1 shared publication - Shaojie Chen
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China
1 shared publication
Latest Publications
- Open Access
- 10 September 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (36) , 21268-21271
Correction: Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer
Correction for ‘Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer’ by Jinmao Zou et al. , Nanoscale , 2020, 12 , 4473–4490, https://doi.org/10.1039/C9NR04976B.
- 10 September 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (36) , 21268-21271
Open AccessCorrection: Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer
Correction for ‘Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer’ by Jinmao Zou et al. , Nanoscale , 2020, 12 , 4473–4490, https://doi.org/10.1039/C9NR04976B.